Surrogate endpoints in clinical trial
Table I from Surrogate markers in HIV disease. | Semantic Scholar
Surrogate markers of infection: interrogation of the immune system | Biomarkers in Medicine
JAHA on Twitter: "New study shows that fractional excretion of urea nitrogen could be a novel surrogate marker of volume status in patients with requiring diuretics. https://t.co/Uk4jUhune2 @TomokiOchiai #AHAJournals https://t.co/9CKo9DxpWm" / Twitter
REBEL Cast Episode 1: Clinically Important Biphasic Anaphylaxis & Total Lymphocyte Count as a Surrogate Marker for CD4 - REBEL EM - Emergency Medicine Blog
Surrogate markers for GHB exposure in cell lines / 978-3-330-03856-1 / 9783330038561 / 333003856X
![PDF] Surrogate outcome markers in research and clinical practice | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/5ae9f320037de4f081b4772e3245508f1d8bc6b3/3-Figure1-1.png "PDF] Surrogate outcome markers in research and clinical practice | Semantic Scholar")
PDF] Surrogate outcome markers in research and clinical practice | Semantic Scholar
Surrogate Markers - TriageMethod
Reasons for failure of surrogate markers in predicting endpoints.... | Download Scientific Diagram
2 Relationship between a surrogate marker and true outcome, adjusted... | Download Scientific Diagram
Defining vitamin D deficiency, using surrogate markers – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.
Cardiovascular surrogate markers and cardiometabolic therapeutics: a viewpoint learned from clinical trials on dipeptidyl peptidase-4 inhibitors | Cardiovascular Diabetology | Full Text
Optimized sensitive and inexpensive method to measure D-lactate as a surrogate marker of methylglyoxal fluxes in metabolically relevant contexts - ScienceDirect
What Do We Know About Surrogate Markers and Disease Outcomes? (Slides with Transcript)
![Therapeutics Initiative | [92] The limitations and potential hazards of using surrogate markers](https://www.ti.ubc.ca/wordpress/wp-content/uploads/2015/10/92.jpg "Therapeutics Initiative | [92] The limitations and potential hazards of using surrogate markers")
Therapeutics Initiative | [92] The limitations and potential hazards of using surrogate markers
Surrogate Endpoints and Biomarkers | Basicmedical Key
FDA Facts: Biomarkers and Surrogate Endpoints | FDA
Copeptin, a surrogate marker for vasopressin, is associated with chronic kidney disease progression in patients with diabetes mellitus (ZODIAC-33) - Media Centre | EASD
Tympanic membrane pressure (TMP) as a surrogate marker of intracranial... | Download Scientific Diagram
Statistical evaluation of surrogate markers: Validity, efficiency, and sensitivity
Surrogate markers are not 'one-size-fits-all' | Cleveland Clinic Journal of Medicine
Surrogate Markers and its role in the Drug Development Process - ppt video online download
Magnetic Resonance Elastography as Surrogate Marker of Interstitial Fibrosis in Kidney Transplantation: A Prospective Study | American Society of Nephrology
Imaging as a surrogate marker of drug efficacy in cardiovascular disease | Heart
Appendix D: Biomarkers Figure | Sodium Intake in Populations: Assessment of Evidence |The National Academies Press
Surrogate Markers for Cardiovascular Disease | Circulation
Reticulocytosis as a Surrogate Marker of Recent Pf Malaria Infection: Association with Clinical, Parasitological and Haematological outcomes: Okoth, Patrick: 9783845437156: Amazon.com: Books
Noninvasive Testing and Surrogate Markers in Invasive Fungal Diseases
Peripheral lymphocyte count as a surrogate marker of immune checkpoint inhibitor therapy outcomes in patients with non-small-cell lung cancer | Scientific Reports
